Global Hospital-Acquired Infections Assays Market Growth (Status and Outlook) 2026-2032
The global Hospital-Acquired Infections Assays market size is predicted to grow from US$ 4875 million in 2025 to US$ 7997 million in 2032; it is expected to grow at a CAGR of 7.5% from 2026 to 2032.
Hospital-acquired infections assays refer to diagnostic tests and assays designed to identify and detect infections that patients may acquire during their stay in healthcare facilities, such as hospitals. These assays play a crucial role in early and accurate diagnosis, enabling healthcare providers to implement timely interventions and prevent the spread of infections within healthcare settings.
The market for hospital-acquired infections assays is driven by the increasing awareness of the importance of infection control in healthcare settings. The assays include a variety of diagnostic tools, such as molecular assays, immunoassays, and microbial culture tests, providing a comprehensive approach to identifying and managing hospital-acquired infections. The need for rapid and accurate diagnostics to reduce the incidence of hospital-acquired infections contributes to the growth of this market.
LPI (LP Information)' newest research report, the ?Hospital-Acquired Infections Assays Industry Forecast? looks at past sales and reviews total world Hospital-Acquired Infections Assays sales in 2025, providing a comprehensive analysis by region and market sector of projected Hospital-Acquired Infections Assays sales for 2026 through 2032. With Hospital-Acquired Infections Assays sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hospital-Acquired Infections Assays industry.
This Insight Report provides a comprehensive analysis of the global Hospital-Acquired Infections Assays landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hospital-Acquired Infections Assays portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Hospital-Acquired Infections Assays market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hospital-Acquired Infections Assays and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hospital-Acquired Infections Assays.
This report presents a comprehensive overview, market shares, and growth opportunities of Hospital-Acquired Infections Assays market by product type, application, key players and key regions and countries.
Segmentation by Type:
Hospital-acquired infections assays refer to diagnostic tests and assays designed to identify and detect infections that patients may acquire during their stay in healthcare facilities, such as hospitals. These assays play a crucial role in early and accurate diagnosis, enabling healthcare providers to implement timely interventions and prevent the spread of infections within healthcare settings.
The market for hospital-acquired infections assays is driven by the increasing awareness of the importance of infection control in healthcare settings. The assays include a variety of diagnostic tools, such as molecular assays, immunoassays, and microbial culture tests, providing a comprehensive approach to identifying and managing hospital-acquired infections. The need for rapid and accurate diagnostics to reduce the incidence of hospital-acquired infections contributes to the growth of this market.
LPI (LP Information)' newest research report, the ?Hospital-Acquired Infections Assays Industry Forecast? looks at past sales and reviews total world Hospital-Acquired Infections Assays sales in 2025, providing a comprehensive analysis by region and market sector of projected Hospital-Acquired Infections Assays sales for 2026 through 2032. With Hospital-Acquired Infections Assays sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hospital-Acquired Infections Assays industry.
This Insight Report provides a comprehensive analysis of the global Hospital-Acquired Infections Assays landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hospital-Acquired Infections Assays portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Hospital-Acquired Infections Assays market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hospital-Acquired Infections Assays and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hospital-Acquired Infections Assays.
This report presents a comprehensive overview, market shares, and growth opportunities of Hospital-Acquired Infections Assays market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Blood Tests
- Urinalysis
- Urinary Tract Infections
- Pneumonia
- Surgical Site Infections
- Bloodstream Infections
- Other Hospital Infections
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BIOM?RIEUX
- Abbott
- F. Hoffmann-La Roche Ltd.
- Siemens Healthcare Private Limited
- BD (Becton, Dickinson and Company)
- Bioscience, Inc.
- QIAGEN
- Thermo Fisher Scientific Inc.
- Meridian Bioscience, Inc.
- Hologic, Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hospital-Acquired Infections Assays Market Size (2021-2032)
2.1.2 Hospital-Acquired Infections Assays Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Hospital-Acquired Infections Assays by Country/Region (2021, 2025 & 2032)
2.2 Hospital-Acquired Infections Assays Segment by Type
2.2.1 Blood Tests
2.2.2 Urinalysis
2.2.3 Hospital-Acquired Infections Assays Market Size by Type
2.2.3.1 Hospital-Acquired Infections Assays Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Hospital-Acquired Infections Assays Market Size Market Share by Type (2021-2026)
2.3 Hospital-Acquired Infections Assays Segment by Application
2.3.1 Urinary Tract Infections
2.3.2 Pneumonia
2.3.3 Surgical Site Infections
2.3.4 Bloodstream Infections
2.3.5 Other Hospital Infections
2.3.6 Hospital-Acquired Infections Assays Market Size by Application
2.3.6.1 Hospital-Acquired Infections Assays Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.6.2 Global Hospital-Acquired Infections Assays Market Size Market Share by Application (2021-2026)
3 HOSPITAL-ACQUIRED INFECTIONS ASSAYS MARKET SIZE BY PLAYER
3.1 Hospital-Acquired Infections Assays Market Size Market Share by Player
3.1.1 Global Hospital-Acquired Infections Assays Revenue by Player (2021-2026)
3.1.2 Global Hospital-Acquired Infections Assays Revenue Market Share by Player (2021-2026)
3.2 Global Hospital-Acquired Infections Assays Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HOSPITAL-ACQUIRED INFECTIONS ASSAYS BY REGION
4.1 Hospital-Acquired Infections Assays Market Size by Region (2021-2026)
4.2 Global Hospital-Acquired Infections Assays Annual Revenue by Country/Region (2021-2026)
4.3 Americas Hospital-Acquired Infections Assays Market Size Growth (2021-2026)
4.4 APAC Hospital-Acquired Infections Assays Market Size Growth (2021-2026)
4.5 Europe Hospital-Acquired Infections Assays Market Size Growth (2021-2026)
4.6 Middle East & Africa Hospital-Acquired Infections Assays Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Hospital-Acquired Infections Assays Market Size by Country (2021-2026)
5.2 Americas Hospital-Acquired Infections Assays Market Size by Type (2021-2026)
5.3 Americas Hospital-Acquired Infections Assays Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hospital-Acquired Infections Assays Market Size by Region (2021-2026)
6.2 APAC Hospital-Acquired Infections Assays Market Size by Type (2021-2026)
6.3 APAC Hospital-Acquired Infections Assays Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hospital-Acquired Infections Assays Market Size by Country (2021-2026)
7.2 Europe Hospital-Acquired Infections Assays Market Size by Type (2021-2026)
7.3 Europe Hospital-Acquired Infections Assays Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hospital-Acquired Infections Assays by Region (2021-2026)
8.2 Middle East & Africa Hospital-Acquired Infections Assays Market Size by Type (2021-2026)
8.3 Middle East & Africa Hospital-Acquired Infections Assays Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HOSPITAL-ACQUIRED INFECTIONS ASSAYS MARKET FORECAST
10.1 Global Hospital-Acquired Infections Assays Forecast by Region (2027-2032)
10.1.1 Global Hospital-Acquired Infections Assays Forecast by Region (2027-2032)
10.1.2 Americas Hospital-Acquired Infections Assays Forecast
10.1.3 APAC Hospital-Acquired Infections Assays Forecast
10.1.4 Europe Hospital-Acquired Infections Assays Forecast
10.1.5 Middle East & Africa Hospital-Acquired Infections Assays Forecast
10.2 Americas Hospital-Acquired Infections Assays Forecast by Country (2027-2032)
10.2.1 United States Market Hospital-Acquired Infections Assays Forecast
10.2.2 Canada Market Hospital-Acquired Infections Assays Forecast
10.2.3 Mexico Market Hospital-Acquired Infections Assays Forecast
10.2.4 Brazil Market Hospital-Acquired Infections Assays Forecast
10.3 APAC Hospital-Acquired Infections Assays Forecast by Region (2027-2032)
10.3.1 China Hospital-Acquired Infections Assays Market Forecast
10.3.2 Japan Market Hospital-Acquired Infections Assays Forecast
10.3.3 Korea Market Hospital-Acquired Infections Assays Forecast
10.3.4 Southeast Asia Market Hospital-Acquired Infections Assays Forecast
10.3.5 India Market Hospital-Acquired Infections Assays Forecast
10.3.6 Australia Market Hospital-Acquired Infections Assays Forecast
10.4 Europe Hospital-Acquired Infections Assays Forecast by Country (2027-2032)
10.4.1 Germany Market Hospital-Acquired Infections Assays Forecast
10.4.2 France Market Hospital-Acquired Infections Assays Forecast
10.4.3 UK Market Hospital-Acquired Infections Assays Forecast
10.4.4 Italy Market Hospital-Acquired Infections Assays Forecast
10.4.5 Russia Market Hospital-Acquired Infections Assays Forecast
10.5 Middle East & Africa Hospital-Acquired Infections Assays Forecast by Region (2027-2032)
10.5.1 Egypt Market Hospital-Acquired Infections Assays Forecast
10.5.2 South Africa Market Hospital-Acquired Infections Assays Forecast
10.5.3 Israel Market Hospital-Acquired Infections Assays Forecast
10.5.4 Turkey Market Hospital-Acquired Infections Assays Forecast
10.6 Global Hospital-Acquired Infections Assays Forecast by Type (2027-2032)
10.7 Global Hospital-Acquired Infections Assays Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Hospital-Acquired Infections Assays Forecast
11 KEY PLAYERS ANALYSIS
11.1 BIOMERIEUX
11.1.1 BIOMERIEUX Company Information
11.1.2 BIOMERIEUX Hospital-Acquired Infections Assays Product Offered
11.1.3 BIOMERIEUX Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 BIOMERIEUX Main Business Overview
11.1.5 BIOMERIEUX Latest Developments
11.2 Abbott
11.2.1 Abbott Company Information
11.2.2 Abbott Hospital-Acquired Infections Assays Product Offered
11.2.3 Abbott Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Abbott Main Business Overview
11.2.5 Abbott Latest Developments
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Company Information
11.3.2 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product Offered
11.3.3 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.3.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.4 Siemens Healthcare Private Limited
11.4.1 Siemens Healthcare Private Limited Company Information
11.4.2 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product Offered
11.4.3 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Siemens Healthcare Private Limited Main Business Overview
11.4.5 Siemens Healthcare Private Limited Latest Developments
11.5 BD (Becton, Dickinson and Company)
11.5.1 BD (Becton, Dickinson and Company) Company Information
11.5.2 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product Offered
11.5.3 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 BD (Becton, Dickinson and Company) Main Business Overview
11.5.5 BD (Becton, Dickinson and Company) Latest Developments
11.6 Bioscience, Inc.
11.6.1 Bioscience, Inc. Company Information
11.6.2 Bioscience, Inc. Hospital-Acquired Infections Assays Product Offered
11.6.3 Bioscience, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Bioscience, Inc. Main Business Overview
11.6.5 Bioscience, Inc. Latest Developments
11.7 QIAGEN
11.7.1 QIAGEN Company Information
11.7.2 QIAGEN Hospital-Acquired Infections Assays Product Offered
11.7.3 QIAGEN Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 QIAGEN Main Business Overview
11.7.5 QIAGEN Latest Developments
11.8 Thermo Fisher Scientific Inc.
11.8.1 Thermo Fisher Scientific Inc. Company Information
11.8.2 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product Offered
11.8.3 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Thermo Fisher Scientific Inc. Main Business Overview
11.8.5 Thermo Fisher Scientific Inc. Latest Developments
11.9 Meridian Bioscience, Inc.
11.9.1 Meridian Bioscience, Inc. Company Information
11.9.2 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product Offered
11.9.3 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Meridian Bioscience, Inc. Main Business Overview
11.9.5 Meridian Bioscience, Inc. Latest Developments
11.10 Hologic, Inc.
11.10.1 Hologic, Inc. Company Information
11.10.2 Hologic, Inc. Hospital-Acquired Infections Assays Product Offered
11.10.3 Hologic, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Hologic, Inc. Main Business Overview
11.10.5 Hologic, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hospital-Acquired Infections Assays Market Size (2021-2032)
2.1.2 Hospital-Acquired Infections Assays Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Hospital-Acquired Infections Assays by Country/Region (2021, 2025 & 2032)
2.2 Hospital-Acquired Infections Assays Segment by Type
2.2.1 Blood Tests
2.2.2 Urinalysis
2.2.3 Hospital-Acquired Infections Assays Market Size by Type
2.2.3.1 Hospital-Acquired Infections Assays Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Hospital-Acquired Infections Assays Market Size Market Share by Type (2021-2026)
2.3 Hospital-Acquired Infections Assays Segment by Application
2.3.1 Urinary Tract Infections
2.3.2 Pneumonia
2.3.3 Surgical Site Infections
2.3.4 Bloodstream Infections
2.3.5 Other Hospital Infections
2.3.6 Hospital-Acquired Infections Assays Market Size by Application
2.3.6.1 Hospital-Acquired Infections Assays Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.6.2 Global Hospital-Acquired Infections Assays Market Size Market Share by Application (2021-2026)
3 HOSPITAL-ACQUIRED INFECTIONS ASSAYS MARKET SIZE BY PLAYER
3.1 Hospital-Acquired Infections Assays Market Size Market Share by Player
3.1.1 Global Hospital-Acquired Infections Assays Revenue by Player (2021-2026)
3.1.2 Global Hospital-Acquired Infections Assays Revenue Market Share by Player (2021-2026)
3.2 Global Hospital-Acquired Infections Assays Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HOSPITAL-ACQUIRED INFECTIONS ASSAYS BY REGION
4.1 Hospital-Acquired Infections Assays Market Size by Region (2021-2026)
4.2 Global Hospital-Acquired Infections Assays Annual Revenue by Country/Region (2021-2026)
4.3 Americas Hospital-Acquired Infections Assays Market Size Growth (2021-2026)
4.4 APAC Hospital-Acquired Infections Assays Market Size Growth (2021-2026)
4.5 Europe Hospital-Acquired Infections Assays Market Size Growth (2021-2026)
4.6 Middle East & Africa Hospital-Acquired Infections Assays Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Hospital-Acquired Infections Assays Market Size by Country (2021-2026)
5.2 Americas Hospital-Acquired Infections Assays Market Size by Type (2021-2026)
5.3 Americas Hospital-Acquired Infections Assays Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hospital-Acquired Infections Assays Market Size by Region (2021-2026)
6.2 APAC Hospital-Acquired Infections Assays Market Size by Type (2021-2026)
6.3 APAC Hospital-Acquired Infections Assays Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hospital-Acquired Infections Assays Market Size by Country (2021-2026)
7.2 Europe Hospital-Acquired Infections Assays Market Size by Type (2021-2026)
7.3 Europe Hospital-Acquired Infections Assays Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hospital-Acquired Infections Assays by Region (2021-2026)
8.2 Middle East & Africa Hospital-Acquired Infections Assays Market Size by Type (2021-2026)
8.3 Middle East & Africa Hospital-Acquired Infections Assays Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HOSPITAL-ACQUIRED INFECTIONS ASSAYS MARKET FORECAST
10.1 Global Hospital-Acquired Infections Assays Forecast by Region (2027-2032)
10.1.1 Global Hospital-Acquired Infections Assays Forecast by Region (2027-2032)
10.1.2 Americas Hospital-Acquired Infections Assays Forecast
10.1.3 APAC Hospital-Acquired Infections Assays Forecast
10.1.4 Europe Hospital-Acquired Infections Assays Forecast
10.1.5 Middle East & Africa Hospital-Acquired Infections Assays Forecast
10.2 Americas Hospital-Acquired Infections Assays Forecast by Country (2027-2032)
10.2.1 United States Market Hospital-Acquired Infections Assays Forecast
10.2.2 Canada Market Hospital-Acquired Infections Assays Forecast
10.2.3 Mexico Market Hospital-Acquired Infections Assays Forecast
10.2.4 Brazil Market Hospital-Acquired Infections Assays Forecast
10.3 APAC Hospital-Acquired Infections Assays Forecast by Region (2027-2032)
10.3.1 China Hospital-Acquired Infections Assays Market Forecast
10.3.2 Japan Market Hospital-Acquired Infections Assays Forecast
10.3.3 Korea Market Hospital-Acquired Infections Assays Forecast
10.3.4 Southeast Asia Market Hospital-Acquired Infections Assays Forecast
10.3.5 India Market Hospital-Acquired Infections Assays Forecast
10.3.6 Australia Market Hospital-Acquired Infections Assays Forecast
10.4 Europe Hospital-Acquired Infections Assays Forecast by Country (2027-2032)
10.4.1 Germany Market Hospital-Acquired Infections Assays Forecast
10.4.2 France Market Hospital-Acquired Infections Assays Forecast
10.4.3 UK Market Hospital-Acquired Infections Assays Forecast
10.4.4 Italy Market Hospital-Acquired Infections Assays Forecast
10.4.5 Russia Market Hospital-Acquired Infections Assays Forecast
10.5 Middle East & Africa Hospital-Acquired Infections Assays Forecast by Region (2027-2032)
10.5.1 Egypt Market Hospital-Acquired Infections Assays Forecast
10.5.2 South Africa Market Hospital-Acquired Infections Assays Forecast
10.5.3 Israel Market Hospital-Acquired Infections Assays Forecast
10.5.4 Turkey Market Hospital-Acquired Infections Assays Forecast
10.6 Global Hospital-Acquired Infections Assays Forecast by Type (2027-2032)
10.7 Global Hospital-Acquired Infections Assays Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Hospital-Acquired Infections Assays Forecast
11 KEY PLAYERS ANALYSIS
11.1 BIOMERIEUX
11.1.1 BIOMERIEUX Company Information
11.1.2 BIOMERIEUX Hospital-Acquired Infections Assays Product Offered
11.1.3 BIOMERIEUX Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 BIOMERIEUX Main Business Overview
11.1.5 BIOMERIEUX Latest Developments
11.2 Abbott
11.2.1 Abbott Company Information
11.2.2 Abbott Hospital-Acquired Infections Assays Product Offered
11.2.3 Abbott Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Abbott Main Business Overview
11.2.5 Abbott Latest Developments
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Company Information
11.3.2 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product Offered
11.3.3 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.3.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.4 Siemens Healthcare Private Limited
11.4.1 Siemens Healthcare Private Limited Company Information
11.4.2 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product Offered
11.4.3 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Siemens Healthcare Private Limited Main Business Overview
11.4.5 Siemens Healthcare Private Limited Latest Developments
11.5 BD (Becton, Dickinson and Company)
11.5.1 BD (Becton, Dickinson and Company) Company Information
11.5.2 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product Offered
11.5.3 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 BD (Becton, Dickinson and Company) Main Business Overview
11.5.5 BD (Becton, Dickinson and Company) Latest Developments
11.6 Bioscience, Inc.
11.6.1 Bioscience, Inc. Company Information
11.6.2 Bioscience, Inc. Hospital-Acquired Infections Assays Product Offered
11.6.3 Bioscience, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Bioscience, Inc. Main Business Overview
11.6.5 Bioscience, Inc. Latest Developments
11.7 QIAGEN
11.7.1 QIAGEN Company Information
11.7.2 QIAGEN Hospital-Acquired Infections Assays Product Offered
11.7.3 QIAGEN Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 QIAGEN Main Business Overview
11.7.5 QIAGEN Latest Developments
11.8 Thermo Fisher Scientific Inc.
11.8.1 Thermo Fisher Scientific Inc. Company Information
11.8.2 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product Offered
11.8.3 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Thermo Fisher Scientific Inc. Main Business Overview
11.8.5 Thermo Fisher Scientific Inc. Latest Developments
11.9 Meridian Bioscience, Inc.
11.9.1 Meridian Bioscience, Inc. Company Information
11.9.2 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product Offered
11.9.3 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Meridian Bioscience, Inc. Main Business Overview
11.9.5 Meridian Bioscience, Inc. Latest Developments
11.10 Hologic, Inc.
11.10.1 Hologic, Inc. Company Information
11.10.2 Hologic, Inc. Hospital-Acquired Infections Assays Product Offered
11.10.3 Hologic, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Hologic, Inc. Main Business Overview
11.10.5 Hologic, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hospital-Acquired Infections Assays Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Hospital-Acquired Infections Assays Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Blood Tests
Table 4. Major Players of Urinalysis
Table 5. Hospital-Acquired Infections Assays Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Hospital-Acquired Infections Assays Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Hospital-Acquired Infections Assays Market Size Market Share by Type (2021-2026)
Table 8. Hospital-Acquired Infections Assays Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Hospital-Acquired Infections Assays Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Hospital-Acquired Infections Assays Market Size Market Share by Application (2021-2026)
Table 11. Global Hospital-Acquired Infections Assays Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Hospital-Acquired Infections Assays Revenue Market Share by Player (2021-2026)
Table 13. Hospital-Acquired Infections Assays Key Players Head office and Products Offered
Table 14. Hospital-Acquired Infections Assays Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hospital-Acquired Infections Assays Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Hospital-Acquired Infections Assays Market Size Market Share by Region (2021-2026)
Table 19. Global Hospital-Acquired Infections Assays Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Hospital-Acquired Infections Assays Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Hospital-Acquired Infections Assays Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Hospital-Acquired Infections Assays Market Size Market Share by Country (2021-2026)
Table 23. Americas Hospital-Acquired Infections Assays Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Hospital-Acquired Infections Assays Market Size Market Share by Type (2021-2026)
Table 25. Americas Hospital-Acquired Infections Assays Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Hospital-Acquired Infections Assays Market Size Market Share by Application (2021-2026)
Table 27. APAC Hospital-Acquired Infections Assays Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Hospital-Acquired Infections Assays Market Size Market Share by Region (2021-2026)
Table 29. APAC Hospital-Acquired Infections Assays Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Hospital-Acquired Infections Assays Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Hospital-Acquired Infections Assays Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Hospital-Acquired Infections Assays Market Size Market Share by Country (2021-2026)
Table 33. Europe Hospital-Acquired Infections Assays Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Hospital-Acquired Infections Assays Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Hospital-Acquired Infections Assays Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Hospital-Acquired Infections Assays Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Hospital-Acquired Infections Assays Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Hospital-Acquired Infections Assays
Table 39. Key Market Challenges & Risks of Hospital-Acquired Infections Assays
Table 40. Key Industry Trends of Hospital-Acquired Infections Assays
Table 41. Global Hospital-Acquired Infections Assays Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Hospital-Acquired Infections Assays Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Hospital-Acquired Infections Assays Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Hospital-Acquired Infections Assays Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. BIOM?RIEUX Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 46. BIOM?RIEUX Hospital-Acquired Infections Assays Product Offered
Table 47. BIOM?RIEUX Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. BIOM?RIEUX Main Business
Table 49. BIOM?RIEUX Latest Developments
Table 50. Abbott Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 51. Abbott Hospital-Acquired Infections Assays Product Offered
Table 52. Abbott Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Abbott Main Business
Table 54. Abbott Latest Developments
Table 55. F. Hoffmann-La Roche Ltd. Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 56. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product Offered
Table 57. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. F. Hoffmann-La Roche Ltd. Main Business
Table 59. F. Hoffmann-La Roche Ltd. Latest Developments
Table 60. Siemens Healthcare Private Limited Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 61. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product Offered
Table 62. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Siemens Healthcare Private Limited Main Business
Table 64. Siemens Healthcare Private Limited Latest Developments
Table 65. BD (Becton, Dickinson and Company) Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 66. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product Offered
Table 67. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. BD (Becton, Dickinson and Company) Main Business
Table 69. BD (Becton, Dickinson and Company) Latest Developments
Table 70. Bioscience, Inc. Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 71. Bioscience, Inc. Hospital-Acquired Infections Assays Product Offered
Table 72. Bioscience, Inc. Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Bioscience, Inc. Main Business
Table 74. Bioscience, Inc. Latest Developments
Table 75. QIAGEN Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 76. QIAGEN Hospital-Acquired Infections Assays Product Offered
Table 77. QIAGEN Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. QIAGEN Main Business
Table 79. QIAGEN Latest Developments
Table 80. Thermo Fisher Scientific Inc. Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 81. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product Offered
Table 82. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Thermo Fisher Scientific Inc. Main Business
Table 84. Thermo Fisher Scientific Inc. Latest Developments
Table 85. Meridian Bioscience, Inc. Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 86. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product Offered
Table 87. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Meridian Bioscience, Inc. Main Business
Table 89. Meridian Bioscience, Inc. Latest Developments
Table 90. Hologic, Inc. Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 91. Hologic, Inc. Hospital-Acquired Infections Assays Product Offered
Table 92. Hologic, Inc. Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Hologic, Inc. Main Business
Table 94. Hologic, Inc. Latest Developments
Table 1. Hospital-Acquired Infections Assays Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Hospital-Acquired Infections Assays Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Blood Tests
Table 4. Major Players of Urinalysis
Table 5. Hospital-Acquired Infections Assays Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Hospital-Acquired Infections Assays Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Hospital-Acquired Infections Assays Market Size Market Share by Type (2021-2026)
Table 8. Hospital-Acquired Infections Assays Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Hospital-Acquired Infections Assays Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Hospital-Acquired Infections Assays Market Size Market Share by Application (2021-2026)
Table 11. Global Hospital-Acquired Infections Assays Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Hospital-Acquired Infections Assays Revenue Market Share by Player (2021-2026)
Table 13. Hospital-Acquired Infections Assays Key Players Head office and Products Offered
Table 14. Hospital-Acquired Infections Assays Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hospital-Acquired Infections Assays Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Hospital-Acquired Infections Assays Market Size Market Share by Region (2021-2026)
Table 19. Global Hospital-Acquired Infections Assays Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Hospital-Acquired Infections Assays Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Hospital-Acquired Infections Assays Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Hospital-Acquired Infections Assays Market Size Market Share by Country (2021-2026)
Table 23. Americas Hospital-Acquired Infections Assays Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Hospital-Acquired Infections Assays Market Size Market Share by Type (2021-2026)
Table 25. Americas Hospital-Acquired Infections Assays Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Hospital-Acquired Infections Assays Market Size Market Share by Application (2021-2026)
Table 27. APAC Hospital-Acquired Infections Assays Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Hospital-Acquired Infections Assays Market Size Market Share by Region (2021-2026)
Table 29. APAC Hospital-Acquired Infections Assays Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Hospital-Acquired Infections Assays Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Hospital-Acquired Infections Assays Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Hospital-Acquired Infections Assays Market Size Market Share by Country (2021-2026)
Table 33. Europe Hospital-Acquired Infections Assays Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Hospital-Acquired Infections Assays Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Hospital-Acquired Infections Assays Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Hospital-Acquired Infections Assays Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Hospital-Acquired Infections Assays Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Hospital-Acquired Infections Assays
Table 39. Key Market Challenges & Risks of Hospital-Acquired Infections Assays
Table 40. Key Industry Trends of Hospital-Acquired Infections Assays
Table 41. Global Hospital-Acquired Infections Assays Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Hospital-Acquired Infections Assays Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Hospital-Acquired Infections Assays Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Hospital-Acquired Infections Assays Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. BIOM?RIEUX Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 46. BIOM?RIEUX Hospital-Acquired Infections Assays Product Offered
Table 47. BIOM?RIEUX Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. BIOM?RIEUX Main Business
Table 49. BIOM?RIEUX Latest Developments
Table 50. Abbott Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 51. Abbott Hospital-Acquired Infections Assays Product Offered
Table 52. Abbott Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Abbott Main Business
Table 54. Abbott Latest Developments
Table 55. F. Hoffmann-La Roche Ltd. Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 56. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product Offered
Table 57. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. F. Hoffmann-La Roche Ltd. Main Business
Table 59. F. Hoffmann-La Roche Ltd. Latest Developments
Table 60. Siemens Healthcare Private Limited Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 61. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product Offered
Table 62. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Siemens Healthcare Private Limited Main Business
Table 64. Siemens Healthcare Private Limited Latest Developments
Table 65. BD (Becton, Dickinson and Company) Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 66. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product Offered
Table 67. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. BD (Becton, Dickinson and Company) Main Business
Table 69. BD (Becton, Dickinson and Company) Latest Developments
Table 70. Bioscience, Inc. Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 71. Bioscience, Inc. Hospital-Acquired Infections Assays Product Offered
Table 72. Bioscience, Inc. Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Bioscience, Inc. Main Business
Table 74. Bioscience, Inc. Latest Developments
Table 75. QIAGEN Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 76. QIAGEN Hospital-Acquired Infections Assays Product Offered
Table 77. QIAGEN Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. QIAGEN Main Business
Table 79. QIAGEN Latest Developments
Table 80. Thermo Fisher Scientific Inc. Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 81. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product Offered
Table 82. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Thermo Fisher Scientific Inc. Main Business
Table 84. Thermo Fisher Scientific Inc. Latest Developments
Table 85. Meridian Bioscience, Inc. Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 86. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product Offered
Table 87. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Meridian Bioscience, Inc. Main Business
Table 89. Meridian Bioscience, Inc. Latest Developments
Table 90. Hologic, Inc. Details, Company Type, Hospital-Acquired Infections Assays Area Served and Its Competitors
Table 91. Hologic, Inc. Hospital-Acquired Infections Assays Product Offered
Table 92. Hologic, Inc. Hospital-Acquired Infections Assays Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Hologic, Inc. Main Business
Table 94. Hologic, Inc. Latest Developments
LIST OF FIGURES
Figure 1. Hospital-Acquired Infections Assays Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hospital-Acquired Infections Assays Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Hospital-Acquired Infections Assays Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Hospital-Acquired Infections Assays Sales Market Share by Country/Region (2025)
Figure 8. Hospital-Acquired Infections Assays Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Hospital-Acquired Infections Assays Market Size Market Share by Type in 2025
Figure 10. Hospital-Acquired Infections Assays in Urinary Tract Infections
Figure 11. Global Hospital-Acquired Infections Assays Market: Urinary Tract Infections (2021-2026) & ($ millions)
Figure 12. Hospital-Acquired Infections Assays in Pneumonia
Figure 13. Global Hospital-Acquired Infections Assays Market: Pneumonia (2021-2026) & ($ millions)
Figure 14. Hospital-Acquired Infections Assays in Surgical Site Infections
Figure 15. Global Hospital-Acquired Infections Assays Market: Surgical Site Infections (2021-2026) & ($ millions)
Figure 16. Hospital-Acquired Infections Assays in Bloodstream Infections
Figure 17. Global Hospital-Acquired Infections Assays Market: Bloodstream Infections (2021-2026) & ($ millions)
Figure 18. Hospital-Acquired Infections Assays in Other Hospital Infections
Figure 19. Global Hospital-Acquired Infections Assays Market: Other Hospital Infections (2021-2026) & ($ millions)
Figure 20. Global Hospital-Acquired Infections Assays Market Size Market Share by Application in 2025
Figure 21. Global Hospital-Acquired Infections Assays Revenue Market Share by Player in 2025
Figure 22. Global Hospital-Acquired Infections Assays Market Size Market Share by Region (2021-2026)
Figure 23. Americas Hospital-Acquired Infections Assays Market Size 2021-2026 ($ millions)
Figure 24. APAC Hospital-Acquired Infections Assays Market Size 2021-2026 ($ millions)
Figure 25. Europe Hospital-Acquired Infections Assays Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Hospital-Acquired Infections Assays Market Size 2021-2026 ($ millions)
Figure 27. Americas Hospital-Acquired Infections Assays Value Market Share by Country in 2025
Figure 28. United States Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Hospital-Acquired Infections Assays Market Size Market Share by Region in 2025
Figure 33. APAC Hospital-Acquired Infections Assays Market Size Market Share by Type (2021-2026)
Figure 34. APAC Hospital-Acquired Infections Assays Market Size Market Share by Application (2021-2026)
Figure 35. China Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 39. India Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Hospital-Acquired Infections Assays Market Size Market Share by Country in 2025
Figure 42. Europe Hospital-Acquired Infections Assays Market Size Market Share by Type (2021-2026)
Figure 43. Europe Hospital-Acquired Infections Assays Market Size Market Share by Application (2021-2026)
Figure 44. Germany Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 45. France Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Hospital-Acquired Infections Assays Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Hospital-Acquired Infections Assays Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Hospital-Acquired Infections Assays Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 58. APAC Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 59. Europe Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 61. United States Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 62. Canada Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 63. Mexico Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 64. Brazil Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 65. China Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 66. Japan Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 67. Korea Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 69. India Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 70. Australia Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 71. Germany Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 72. France Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 73. UK Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 74. Italy Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 75. Russia Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 76. Egypt Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 77. South Africa Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 78. Israel Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 79. Turkey Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 80. Global Hospital-Acquired Infections Assays Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Hospital-Acquired Infections Assays Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 1. Hospital-Acquired Infections Assays Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hospital-Acquired Infections Assays Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Hospital-Acquired Infections Assays Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Hospital-Acquired Infections Assays Sales Market Share by Country/Region (2025)
Figure 8. Hospital-Acquired Infections Assays Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Hospital-Acquired Infections Assays Market Size Market Share by Type in 2025
Figure 10. Hospital-Acquired Infections Assays in Urinary Tract Infections
Figure 11. Global Hospital-Acquired Infections Assays Market: Urinary Tract Infections (2021-2026) & ($ millions)
Figure 12. Hospital-Acquired Infections Assays in Pneumonia
Figure 13. Global Hospital-Acquired Infections Assays Market: Pneumonia (2021-2026) & ($ millions)
Figure 14. Hospital-Acquired Infections Assays in Surgical Site Infections
Figure 15. Global Hospital-Acquired Infections Assays Market: Surgical Site Infections (2021-2026) & ($ millions)
Figure 16. Hospital-Acquired Infections Assays in Bloodstream Infections
Figure 17. Global Hospital-Acquired Infections Assays Market: Bloodstream Infections (2021-2026) & ($ millions)
Figure 18. Hospital-Acquired Infections Assays in Other Hospital Infections
Figure 19. Global Hospital-Acquired Infections Assays Market: Other Hospital Infections (2021-2026) & ($ millions)
Figure 20. Global Hospital-Acquired Infections Assays Market Size Market Share by Application in 2025
Figure 21. Global Hospital-Acquired Infections Assays Revenue Market Share by Player in 2025
Figure 22. Global Hospital-Acquired Infections Assays Market Size Market Share by Region (2021-2026)
Figure 23. Americas Hospital-Acquired Infections Assays Market Size 2021-2026 ($ millions)
Figure 24. APAC Hospital-Acquired Infections Assays Market Size 2021-2026 ($ millions)
Figure 25. Europe Hospital-Acquired Infections Assays Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Hospital-Acquired Infections Assays Market Size 2021-2026 ($ millions)
Figure 27. Americas Hospital-Acquired Infections Assays Value Market Share by Country in 2025
Figure 28. United States Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Hospital-Acquired Infections Assays Market Size Market Share by Region in 2025
Figure 33. APAC Hospital-Acquired Infections Assays Market Size Market Share by Type (2021-2026)
Figure 34. APAC Hospital-Acquired Infections Assays Market Size Market Share by Application (2021-2026)
Figure 35. China Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 39. India Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Hospital-Acquired Infections Assays Market Size Market Share by Country in 2025
Figure 42. Europe Hospital-Acquired Infections Assays Market Size Market Share by Type (2021-2026)
Figure 43. Europe Hospital-Acquired Infections Assays Market Size Market Share by Application (2021-2026)
Figure 44. Germany Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 45. France Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Hospital-Acquired Infections Assays Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Hospital-Acquired Infections Assays Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Hospital-Acquired Infections Assays Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Hospital-Acquired Infections Assays Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 58. APAC Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 59. Europe Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 61. United States Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 62. Canada Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 63. Mexico Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 64. Brazil Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 65. China Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 66. Japan Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 67. Korea Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 69. India Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 70. Australia Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 71. Germany Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 72. France Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 73. UK Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 74. Italy Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 75. Russia Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 76. Egypt Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 77. South Africa Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 78. Israel Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 79. Turkey Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
Figure 80. Global Hospital-Acquired Infections Assays Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Hospital-Acquired Infections Assays Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Hospital-Acquired Infections Assays Market Size 2027-2032 ($ millions)
